0001209191-19-009103.txt : 20190211 0001209191-19-009103.hdr.sgml : 20190211 20190211182504 ACCESSION NUMBER: 0001209191-19-009103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190211 FILED AS OF DATE: 20190211 DATE AS OF CHANGE: 20190211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Di Donato Brian CENTRAL INDEX KEY: 0001766498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33095 FILM NUMBER: 19587011 MAIL ADDRESS: STREET 1: C/O ACHILLION PHARMACEUTICALS, INC STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACHILLION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070336 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-624-7000 MAIL ADDRESS: STREET 1: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-11 0 0001070336 ACHILLION PHARMACEUTICALS INC ACHN 0001766498 Di Donato Brian C/O ACHILLION PHARMACEUTICALS, INC. 300 GEORGE STREET NEW HAVEN CT 06511 0 1 0 0 Chief Financial Officer Stock Option (Right to buy) 2.29 2019-02-11 4 A 0 500000 0.00 A 2029-02-11 Common Stock 500000 500000 D This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter. /s/ Brian Di Donato 2019-02-11